Immunity to mycobacteria with emphasis on tuberculosis: Implications for rational design of an effective tuberculosis vaccine

Chemical Immunology

Volumn 70, Issue , 1998, Pages 21-59

  Kaufmann, Stefan H E ^a,b   Andersen, Peter ^c  

^a UNIVERSITY OF ULM   (Germany)

^b MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; BCG VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; DRUG CARRIER; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; LIVE VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYCOBACTERIUM ANTIGEN; MYCOBACTERIUM VACCINE; PROTEIN SUBUNIT; RECOMBINANT PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; BACTERIAL IMMUNITY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; LEPROSY; LUNG INFECTION; MACROPHAGE; MYCOBACTERIOSIS; MYCOBACTERIUM; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; VACCINE PRODUCTION;

EID: 0031963997     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058699     Document Type: Review

References (240)

1. Grange JM (ed): Mycobacteria and Human Disease, ed 2. London, Arnold, 1996.
2. Bloom BR, Murray CJL: Tuberculosis: Commentary on reemergent killer. Science 1992;257:1055-1064.
3. Kaufmann SHE, Van Embden JDA: Tuberculosis: A neglected disease strikes back. Trends Microbiol 1993;1:2-5.
4. Davies PDO (ed): Clinical Tuberculosis. London, Chapman & Hall, 1994.
5. Hastings RC (ed): Leprosy, ed 2. Edinburgh, Churchill Livingstone, 1994.
6. Inderlied CB, Kemper CA, Bermudez LE: The Mycobacterium avium complex. Clin Microbiol Rev 1993;6:266-310.
7. Brennan PJ, Nikaido H: The envelope of mycobacteria. Annu Rev Biochem 1995;64:29-63.
8. Porcelli SA, Morita CT, Modlin RL: T-cell recognition of non-peptide antigens. Curr Opin Immunol 1996;8:510-516.
9. Kaufmann SHE: Tuberculosis: The role of the immune response. Immunologist 1993;1:109-114.
10. Kaufmann SHE: Cell-mediated immunity; in Hastings RC (ed): Leprosy, ed 2. Edinburgh, Churchill Livingstone, 1993, pp 157-168.
11. Bloom BR, Modlin RL, Salgame P: Stigma variations: Observations on suppressor T cells and leprosy. Annu Rev Immunol 1992;10:453-488.
12. Barnes PF, Modlin RL: Human cellular immune responses to Mycobacterium tuberculosis. Curr Top Microbiol Immunol 1996;215:197-220.
13. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schecter GF, Daley CL, Schoolnik GK: The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703-1709.
14. + T cells. Infect Immun 1987;55:2037-2041.
15. Orme IM, Collins FM: Adoptive protection of the Mycobacterium tuberculosis infected lung: Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell Immunol 1984;84:113-120.
16. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR: Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992;89:12013-12017.
17. + T cells in vitro. Immunology 1996;87:339-342.
18. Rees ADM, Scoging A, Mehlert A, Young DB, Ivanyi J: Specificity of proliferative response of human CD8 clones to mycobacterial antigens. Eur J Immunol 1988;18:1881-1887.
19. + T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein. J Exp Med 1990;171:667-679.
20. Modlin RL, Pirmez C, Hofmann FM, Torigian V, Uyemura K, Rea TH, Bloom BR, Brenner MB: Lymphocytes bearing antigen-specific γ/δ T-cell receptors accumulate in human infectious disease lesions. Nature 1989;339:544-548.
21. Kaufmann SHE: γ/δ and other unconventional T lymphocytes: What do they see and what do they do? Proc Natl Acad Sci USA 1996;93:2272-2279.
22. Ladel CH, Hess J, Daugelat S, Mombaerts P, Tonegawa S, Kaufmann SHE: Contribution of αβ and γ/δ T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette-Guérin: Studies with T cell receptor-deficient mutant mice. Eur J Immunol 1995;25:838-846.
23. + T cells. Nature 1994;372:691-694.
24. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, Soriano T, Bloom BR, Brenner MB, Kronenberg M, Brennan PJ, Modlin RL: CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 1995;269:227-230.
25. Germain RN: MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 1994;76:287-299.
26. + T lymphocytes in intracellular microbial infections. Immunol Today 1988; 9:168-174.
27. Russell DG: Mycobacterium and leishmania: Stowaways in the endosomal network. Trends Cell Biol 1995;5:125-128.
28. McDonough KA, Kress Y, Bloom BR: Pathogenesis of tuberculosis: Interaction of Mycobacterium tuberculosis with macrophages. Infect Immun 1993;61:2763-2773.
29. Mor N: Intracellular location of Mycobacterium leprae in macrophages of normal and immune-deficient mice and effect of rifampin. Infect Immun 1983;42:802-811.
30. Ladel CH, Daugelat S, Kaufmann SHE: Immune response to Mycobacterium bovis bacille Calmette-Guérin infection in major histocompatibility complex class I-and II-deficient knock-out mice: Contribution of CD4 and CD8 T cells to acquired resistance. Eur J Immunol 1995;25:377-384.
31. Jondal M, Schirmbeck R, Reimann J: MHC class I-restricted CTL responses to exogenous antigens. Immunity 1996;5:295-302.
32. Harding CV: Class I MHC presentation of exogenous antigens. J Clin Immunol 1996;16:90-96.
33. + T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 1989;142:1114-1119.
34. Emmrich F, Kaufmann SHE: Human T cell clones with reactivity to Mycobacterium leprae as tools for the characterization of candidate vaccines against leprosy. Infect Immun 1986;41:879-883.
35. Orme IM: Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J Immunol 1988;140:3589-3593.
36. Orme IM: The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol 1987;138:293-298.
37. + cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guérin in mice. Assessment by elimination of T cell subsets in vivo. J Immunol 1987;139:2032-2037.
38. Raulet DH: MHC class I-deficient mice. Adv Immunol 1994;55:381-421.
39. Porcelli SA: The CD1 family: A third lineage of antigen-presenting molecules. Adv Immunol 1995; 59:1-98.
40. 2-microglobulin-deficient mice. Immunol Lett 1994;39:105-111.
41. O'Brien L, Roberts B, Andrew PW: In vitro interaction of Mycobacterium tuberculosis and macrophages: Activation of anti-mycobacterial activity of macrophages and mechanisms of anti-mycobacterial activity. Curr Top Microbiol Immunol 1996;215:97-130.
42. Nabeshima S, Hiromatsu K, Matsuzaki G, Mukasa A, Takada H, Yoshida S, Nomoto K: Infection of Mycobacterium bovis bacillus Calmette-Guérin in antibody-mediated γδ cell-depleted mice. Immunology 1995;84:317-321.
43. Ladel CH, Blum C, Dreher A, Reifenberg K, Kaufmann SHE: Protective role of γ/δ T cells and α/β T cells in tuberculosis. Eur J Immunol 1995;25:2877.
44. Falini B, Flenghi L, Pileri S, Pelicci P, Fagioli M, Martelli MF, Moretta L, Ciccone E: Distribution of T cells bearing different forms of the T cell receptor γ/δ in normal and pathological human tissues. J Immunol 1989;143:2480-2488.
45. Tazi A, Fajac I, Soler P, Valeyre D, Battesti JP, Hance AJ: Gamma/delta T lymphocytes are not increased in number in granulomatous lesions of patients with tuberculosis or sarcoidosis. Am Rev Respir Dis 1991;144:1373-1375.
46. Pfeffer K, Schoel B, Gulle H, Kaufmann SHE, Wagner H: Primary responses of human T cells to mycobacteria: A frequent set of γ/δ T cells are stimulated by protease-resistant ligands. Eur J Immunol 1990;20:1175-1179.
47. Constant P, Davodeau F, Peyrat M-A, Poquet Y, Puzo G, Bonneville M, Fournié J-J: Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 1994;264:267-270.
48. Tanaka Y, Sano S, Nieves E, De Libero G, Rosa D, Modlin RL, Brenner MB, Bloom BR, Morita CT: Nonpeptide ligands for human γδ T cells. Proc Natl Acad Sci USA 1994;91:8175-8179.
49. Schoel B, Sprenger S, Kaufmann SHE: Phosphate is essential for stimulation of Vγ9Vδ2 T lymphocytes by mycobacterial low molecular weight ligand. Eur J Immunol 1994;24:1886-1892.
50. Tanaka Y, Morita CT, Nieves E, Brenner MB, Bloom BR: Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 1995;375:155-158.
51. Morita CT, Beckman EM, Bukowski JF, Tanaka Y, Band H, Bloom BR, Golan DE, Brenner MB: Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells. Immunity 1995;3:495-508.
52. Boom WH, Balaji KN, Nayak R, Tsukaguchi K, Chervenak KA: Characterization of a 10-to 14-kilodalton protease-sensitive Mycobacterium tuberculosis H37Ra antigen that stimulates human γδ T cells. Infect Immun 1994;62:5511-5518.
53. Munk ME, Elser C, Kaufmann SHE: Human γ/δ T cell response to Listeria monocytogenes protein components in vitro. Immunology 1996;87:235.
54. O'Brien RL, Happ MP, Dallas A, Palmer E, Kubo R, Born WK: Stimulation of a major subset of lymphocytes expressing T cell receptor γ/δ by an antigen derived from Mycobacterium tuberculosis. Cell 1989;57:667-674.
55. Beckman EM, Melian AM, Behar SM, Sieling PA, Chatterjee D, Matsumoto R, Rosat J-P, Modlin RL, Porcelli SA: CD1c restricts responses of mycobacteria-specific T cells: Evidence for antigen presentation by a second member of the human CD1 family. J Immunol 1996;157:2795-2803.
56. Sugita M, Jackman RM, van Donselaar E, Behar SM, Rogers RA, Peters PJ, Brenner MB, Porcelli SA: Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science 1996;273:349-352.
57. Chan J, Kaufmann SHE. Immune mechanisms of protection; in Bloom BR (ed): Tuberculosis: Pathogenesis, Protection, and Control. Washington, ASM, 1994, pp 389-415.
58. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996;383: 787-793.
59. Murray HW: Interferon-gamma and host antimicrobial defense: Current and future clinical applications. Am J Med 1994;97:459-467.
60. Trinchieri G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-276.
61. Zhang M, Gately MK, Wang E, Gong J, Wolf SF, Lu S, Modlin RL, Barnes PF: Interleukin-12 at the site of disease in tuberculosis. J Clin Invest 1994;93:1733-1739.
62. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR: An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-2254.
63. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM: Disseminated tuberculosis in interferon-γ gene-disrupted mice. J Exp Med 1993;178:2249-2254.
64. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M: Immune response in mice that lack the interferon-γ receptor. Science 1993;259:1742-1745.
65. Orme IM, Roberts AD, Griffin JP, Abrams JS: Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993;151:518-525.
66. Surcel H-M, Troye-Blomberg M, Paulie S, Andersson G, Moreno C, Pasvol G: Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994;81:171-176.
67. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-549.
68. + T cells producing Th2-type cytokines. FASEB J 1995;9:81-86.
69. + T cells are induced by Mycobacterium tuberculosis and present in tuberculosis lesions. Int Immunol 1997;9:713-720.
70. Sher A, Coffman RL: Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992;10:385-410.
71. Lindblad EB, Elhay MJ, Silva R, Appelberg R, Andersen P: Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect Immun 1997;65:623-629.
72. Dinarello CA: Role of interleukin-1 in infectious diseases. Immunol Rev 1992;127:119-146.
73. Akira S, Taga T, Kishimoto T: Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78.
74. Tracey KJ, Cerami A: Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993; 9:317-343.
75. Law K, Weiden M, Harkin T, Tchou Wong K, Chi C, Rom WN: Increased release of interleukin-1β, interleukin-6, and tumor necrosis factor-α by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med 1996;153:799-804.
76. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR: Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995;2:561-572.
77. Kindler V, Sappino A-P, Grau Ge, Piquet P-F, Vassalli P: The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989;56:731-740.
78. Flesch IEA, Kaufmann SHE: Mechanisms involved in mycobacterial growth inhibition by gamma-interferon activated bone marrow macrophages: Role of reactive nitrogen intermediates. Infect Immun 1991;59:3213-3218.
79. Sampaio EP, Kaplan G, Miranda A, Nery JA, Miguel CP, Viana SM, Sarno EN: The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. J Infect Dis 1993;168:408-414.
80. Tramontana JM, Utaipat U, Molloy A, Akarasewi P, Burroughs M, Makonkawkeyoon S, Johnson B, Klausner JD, Rom W, Kaplan G: Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med 1995;1: 384-397.
81. Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G: Thalidomide selectively inhibits tumor necrosis factor-α production by stimulated human monocytes. J Exp Med 1991;173:699-703.
82. Flesch IEA, Kaufmann SHE: Stimulation of antibacterial macrophage activities by B cell stimulatory factor 2/interleukin-6. Infect Immun 1990;58:269-271.
83. Appelberg R, Castro AG, Pedrosa J, Minoprio P: Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice. Immunology 1994;82:361-364.
84. 83a Ladel C, Blum C, Dreher A, Reifenberg K, Kopf M, Kaufman SHE: Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 1997;65:4543-4549.
85. Mackay CR: Chemokine receptors and T cell chemotaxis. J Exp Med 1996;184:799-802.
86. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994;55:97-179.
87. Rhoades ER, Cooper AM, Orme IM: Chemokine response in mice infected with Mycobacterium tuberculosis. Infect Immun 1995;63:3871-3877.
88. Zhang Y, Broser M, Cohen H, Bodkin M, Law K, Reibman J, Rom WN: Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J Clin Invest 1995;95:586-592.
89. Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Gladue RP, Corless CL, Rollins BJ: High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 1995;155:4838-4843.
90. Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, Bloom BR: IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 1995;155:2515-2524.
91. Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM: The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 1995;85:423-432.
92. Frucht DM, Holland SM: Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: Abnormal IL-12 regulation. J Immunol 1996;157:411-416.
93. Castro AG, Silva RA, Appelberg R: Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice. J Immunol 1995;155:2013-2019.
94. Flesch IEA, Hess JH, Huang S, Aguet M, Rothe J, Bluethmann H, Kaufmann SHE: Early interleukin-12 production by macrophages in response to mycobacterial infection depends on interferon-γ and tumor necrosis factor-α. J Exp Med 1995;181:1615-1621.
95. 93a Ladel CH, Szalay G, Riedel D, Kaufmann SHE: Interleukin-12 secretion in Mycobacterium tuberculosis-infected macrophages. Infect Immun 1997;65:1936-1938
96. Douvas GS, Looker DL, Vatter AE, Crowle AJ: Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun 1985;50:1-8.
97. Flesch I, Kaufmann SHE: Mycobacterial growth inhibition by interferon-γ activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J Immunol 1987;138:4408-4413.
98. Denis M: Killing of Mycobacterium tuberculosis within human monocytes: Activation by cytokines and calcitriol. Clin Exp Immunol 1991;84:200-206.
99. 3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986;57:159-163.
100. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, Levin M, Blanche S, Seboun E, Fischer A, Casanova J-L: Interferon gamma receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med 1996;335:1956-1961.
101. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M: A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996;335:1941-1949.
102. Sander B, Skansen-Saphir U, Damm O, Hakansson L, Andersson J: Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin. Immunology 1995;86:512-518.
103. Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF: Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 1996;64:1351-1356.
104. Conradt P, Kaufmann SHE: Impact of antigen presenting cells on cytokine profiles of human Th clones established after stimulation with Mycobacterium tuberculosis antigens. Infect Immun 1995; 63:2079-2081.
105. + T cells. Curr Opin Immunol 1995;7:367-374.
106. pos T cells promptly produce interleukin-4 in response to in vivo challenge with anti-CD3. J Exp Med 1994;179:1285-1295.
107. 2-microglobulin, and NK1.1 expression. Int Immunol 1995;7:1729-1739.
108. + T lymphocytes. Eur J Immunol 1997;27:183-188.
109. Wahl SM: Transforming growth factor β: The good, the bad, and the ugly. J Exp Med 1994;180: 1587-1590.
110. Dahl KE, Shiratsuchi H, Hamilton BD, Ellner JJ, Toossi Z: Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect Immun 1996;64:399-405.
111. Hirsch CS, Hussain R, Toossi Z, Dawood G, Shahid F, Ellner JJ: Cross-modulation by transforming growth factor beta in human tuberculosis: Suppression of antigen-driven blastogenesis and interferon gamma production. Proc Natl Acad Sci USA 1996;93:3193-3198.
112. + T cell lines. Eur J Immunol 1988;18:59-66.
113. Kumararatne DS, Pithie AS, Drysdale P, Gaston JS, Kiessling R, Iles PB, Ellis CJ, Innes J, Wise R: Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosis. Clin Exp Immunol 1990;80:314-323.
114. + cytotoxic T cells from BCG vaccinated healthy subjects: Relation between cytotoxicity and suppression in vitro. Clin Exp Immunol 1987;69:255-262.
115. McDonough KA, Kress Y: Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect Immun 1995,63:4802-4811
116. Chan J, Fujiwara T, Brennan P, McNeil M, Turco SJ, Sibille JC, Snapper M, Aisen P, Bloom BR: Microbial glycolipids: Possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci USA 1989;86:2453-2457.
117. + T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol 1994;24: 3068-3072.
118. Laochumroonvorapong P, Wang J, Liu C-C, Ye W, Moreira A, Elkon K, Freedman VH, Kaplan G: Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun 1997;65:127-132.
119. Cerottini JC, MacDonald HR: The cellular basis of T-cell immunology. Annu Rev Immunol 1989; 7:77-89.
120. + T lymphocytes different from unprimed cells? Eur J Immunol 1994;24:1073-1079.
121. Mackay CR: T-cell memory: The connection between function, phenotype and migration pathways. Immunol Today 1991;12:189-192.
122. Bradley LM, Duncan DD, Yoshimoto K, Swain SL: Memory effectors: A potent, IL-4-secreting helper T cell population that develops in vivo after restimulation with antigen. J Immunol 1993; 150:3119-3130.
123. Lefford MJ, McGregor DD: Immunological memory in tuberculosis. I. Influence of persisting viable organisms. Cell Immunol 1974;14:417-428.
124. North RJ: Nature of 'memory' in T-cell-mediated antibacterial immunity: Anamnestic production of mediator T cells. Infect Immun 1975;12:754-760.
125. Andersen P, Andersen AB, Sorensen AL, Nagai S: Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol 1995;154:3359-3372.
126. Dianzani U, Luqman M, Rojo J, Yagi J, Baron JL, Woods A, Janeway CA, Bottomly K: Molecular associations on the T cell surface correlate with immunological memory. Eur J Immunol 1990;20: 2249-2257.
127. Griffin JP, Harshan KV, Born WK, Orme IM: Kinetics of accumulation of gamma delta receptor-bearing T lymphocytes in mice infected with live mycobacteria. Infect Immun 1991;59:4263-4265.
128. Bell EB, Sparshott SM: Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 1990; 348:163-166.
129. Sprent J, Tough DF: Lymphocyte life-span and memory. Science 1994;265:1395-1400.
130. Michie CA, McLean A, Alcock C, Beverley PC: Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 1992;360:264-265.
131. Tough DF, Sprent J: Turnover of naive-and memory-phenotype T cells. J Exp Med 1994;179: 1127-1135.
132. Brandt L, Oettinger T, Holm A, Andersen P: Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 1996;157: 3527-3533.
133. Andersen P, Heron I: Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun 1993;61:844-851.
134. Closs O, Harboe M, Axelsen NH, Bunch-Christensen K, Magnusson M: The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: A reference system. Scand J Immunol 1980;12:249-263.
135. Bergh S, Cole ST: MycDB: An integrated mycobacterial database. Mol Microbiol 1994;12:517-534.
136. Andersen P: Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand J Immunol 1997;45:115-131.
137. Andersen P, Askgaard D, Ljungqvist L, Bennedsen J, Heron I: Proteins released from Mycobacterium tuberculosis during growth. Infect Immun 1991;59:1905-1910.
138. Daugelat S, Guile H, Schoel B, Kaufmann SH: Secreted antigens of Mycobacterium tuberculosis: Characterization with T lymphocytes from patients and contacts after two-dimensional separation. J Infect Dis 1992;166:186-190.
139. Lee BY, Hefta SA, Brennan PJ: Characterization of the major membrane protein of virulent Mycobacterium tuberculosis. Infect Immun 1992;60:2066-2074.
140. Nagai S, Wiker HG, Harboe M, Kinomoto M: Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun 1991;59:372-382.
141. Kadival GV, Chaparas SD, Hussong D: Characterization of serologic and cell-mediated reactivity of a 38-kDa antigen isolated from Mycobacterium tuberculosis. J Immunol 1987;139:2447-2451.
142. Young RA, Bloom BR, Grosskinsky CM, Ivanyi J, Thomas D, Davis RW: Dissection of Mycobacterium tuberculosis antigens using recombinant DNA. Proc Natl Acad Sci USA 1985;82:2583-2587.
143. Mustafa AS, Oftung F, Deggerdal A, Gill HK, Young RA, Godal T: Gene isolation with human T lymphocyte probes. Isolation of a gene that expresses an epitope recognized by T cells specific for Mycobacterium bovis BCG and pathogenic mycobacteria. J Immunol 1988;141:2729-2733.
144. Boesen H, Jensen BN, Wilcke T, Andersen P: Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun 1995;63:1491-1497.
145. Kawamura I, Yang J, Takaesu Y, Fujita M, Nomoto K, Mitsuyama M: Antigen provoking gamma interferon production in response to Mycobacterium bovis BCG and functional difference in T-cell responses to this antigen between viable and killed BCG-immunized mice. Infect Immun 1994;62: 4396-4403.
146. Ben-Nun A, Mendel I, Sappler G, Kerlero-de-Rosbo N: A 12-kDa protein of Mycobacterium tuberculosis protects mice against experimental autoimmune encephalomyelitis. Protection in the absence of shared T cell epitopes with encephalitogenic proteins. J Immunol 1995;154:2939-2948.
147. Roche PW, Winter N, Triccas JA, Feng CG, Britton WJ: Expression of Mycobacterium tuberculosis MPT64 in recombinant Mycobacterium smegmatis: Purification, immunogenicity and application to skin tests for tuberculosis. Clin Exp Immunol 1996;103:226-232.
148. Herrmann JL, O'Gaora PO, Gallagher A, Thole JER, Young DB: Bacterial glycoproteins: A link between glycosylation and proteolytic cleavage of a 19 kDa antigen from Mycobacterium tuberculosis. EMBO J 1996;15:3547-3554.
149. Young DB, Lamb JR: T lymphocytes respond to solid-phase antigen: A novel approach to the molecular analysis of cellular immunity. Immunology 1986;59:167-171.
150. Mehra V, Bloom BR, Torigian VK, Mandich D, Reichel M, Young SM, Salgame P, Convit J, Hunter SW, McNeil M, Brennan PJ, Rea TH, Modlin RL: Characterization of Mycobacterium leprae cell wall-associated proteins with the use of T lymphocyte clones. J Immunol 1989;142: 2873-2878.
151. Torres M, Mendez-Sampeiro P, Jimenez-Zamudio L, Teran L, Camarena A, Quezada R, Ramos E, Sada E: Comparison of the immune response against Mycobacterium tuberculosis antigens between a group of patients with active pulmonary tuberculosis and healthy household contacts. Clin Exp Immunol 1994;96:75-78.
152. Andersen P, Askgaard D, Gottschau A, Bennedsen J, Nagai S, Heron I: Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol 1992;36: 823-831.
153. Gulle H, Schoel B, Kaufmann SH: Direct blotting with viable cells of protein mixtures separated by two-dimensional gel electrophoresis. J Immunol Methods 1990;133:253-261.
154. Andersen P, Heron I: Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods 1993;161:29-39.
155. Schoel B, Gulle H, Kaufmann SH: Heterogeneity of the repertoire of T cells of tuberculosis patients and healthy contacts to Mycobacterium tuberculosis antigens separated by high-resolution techniques. Infect Immun 1992;60:1717-1720.
156. Hasløv K, Andersen A, Nagai S, Gottschau A, Sorensen T, Andersen P: Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect Immun 1995;63:804-810.
157. 154a Pollock JM, Andersen P: The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis. J Infect Dis 1997;175:1251-1254.
158. 154b Pollock JM, Andersen P: Predominant recognition of the ESAT-6 in the first phase of infection with Mycobacterium bovis in cattle. Infect Immun 1997;65:2587-2592.
159. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB: Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995; 63:1710-1717.
160. Alavi MR, Affronti LF: Induction of mycobacterial proteins during phagocytosis and heat shock: A time interval analysis. J Leukoc Biol 1994;55:633-641.
161. Lee BY, Horwitz MA: Identification of macrophage and stress-induced proteins of Mycobacterium tuberculosis. J Clin Invest 1995;96:245-249.
162. Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB: Vaccination against tuberculosis by DNA injection. Nat Med 1996;2:888-892.
163. Hess J, Gentschev I, Miko D, Welzel M, Ladel C, Goebel W, Kaufmann SH: Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc Natl Acad Sci USA 1996;93:1458-1463.
164. 159a Hess J, Dietrich G, Gentschev I, Miko D, Goebel W, Kaufmann SHE: Protection against murine listeriosis by an attenuated recombinant Salmonella typhimurium vaccine secreting the naturally somatic antigen superoxide dismutase. Infect Immun 1997;65:1286-1292.
165. Smith DW: Protective effect of BCG in experimental tuberculosis. Adv Tuberc Res 1985;22:1-97.
166. Fine PE: The BCG story: Lessons from the past and implications for the future. Rev Infect Dis 1989;11 (suppl 2):353-359.
167. Fine PE: Variation in protection by BCG: Implications of and for heterologous immunity. Lancet 1995;346:1339-1345.
168. Hart PD, Sutherland I: BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J 1977;ii:293-295.
169. Dahlstrom G: Tuberculosis in BCG vaccinated and non-vaccinated young adults. A comparative prognostic study. Acta Tuberc Scand 1953;suppl 32.
170. Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV: The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: Meta-analyses of the published literature. Pediatrics 1995;96:29-35.
171. al-Kassimi FA, al-Hajjaj MS, al-Orainey IO, Bamgboye EA: Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction? Am J Respir Crit Care Med 1995;152: 1575-1578.
172. Stanford JL, Shield MJ, Rook GA: How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle 1981;62:55-62.
173. Rook GA, Bahr GM, Stanford JL: The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG. Tubercle 1981;62:63-68.
174. Palmer CE, Long MW: Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis 1966;94:553-568.
175. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P: Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996;64:16-22.
176. Ravn P, Boesen H, Pedersen BK, Andersen P: Human T cell responses induced by vaccination with M. bovis bacillus Calmette-Guérin. J Immunol 1997;58:1949-1955.
177. Ribi E, Larson C, Wicht W, List R, Goode G: Effective nonliving vaccine against experimental tuberculosis in mice. J Bacteriol 1966;91:975-983.
178. Ribi E, Anacker RL, Brehmer W, Goode G, Larson CL, List RH, Milner KC, Wicht WC: Factors influencing protection against experimental tuberculosis in mice by heat-stable cell wall vaccines. J Bacteriol 1966;92:869-879.
179. Masihi KN, Brehmer W, Azuma I, Lange W, Muller S: Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate. Infect Immun 1984;43:233-237.
180. Masihi KN, Lange W, Brehmer W, Ribi E: Immunobiological activities of nontoxic lipid A: Enhancement of nonspecific resistance in combination with
181. Mackaness GB: The relationship of delayed hypersensitivity to acquired cellular resistance. Br Med Bull 1967;23:52-54.
182. Orme IM: Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun 1988;56:3310-3312.
183. Orme IM, Andersen P, Boom WH: T cell response to Mycobacterium tuberculosis. J Infect Dis 1993;167:1481-1497.
184. Andersen P: Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 1994;62:2536-2544.
185. Horwitz MA, Lee BW, Dillon BJ, Harth G: Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1995;92:1530-1534.
186. Roberts AD, Sonnenberg MG, Ordway DJ, Furney SK, Brennan PJ, Belisle JT, Orme IM: Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 1995;85:502-508.
187. Hubbard RD, Flory CM, Collins FM: Immunization of mice with mycobacterial culture filtrate proteins. Clin Exp Immunol 1992;87:94-98.
188. Pal PG, Horwitz MA: Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun 1992;60:4781-4792.
189. Bomford R: The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin. Clin Exp Immunol 1980;39:435-441.
190. Bomford R: The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin. Clin Exp Immunol 1980;39:426-434.
191. + cytotoxic T lymphocytes towards soluble antigens: Immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide. Eur J Immunol 1991;21:1523-1527.
192. Snapper SB, Lugosi L, Jekkel A, Melton RE, Kieser T, Bloom BR, Jacobs WR: Lysogeny and transformation in mycobacteria: Stable expression of foreign genes. Proc Natl Acad Sci USA 1988; 85:6987-6991.
193. Husson RN, James BE, Young RA: Gene replacement and expression of foreign DNA in mycobacteria. J Bacteriol 1990;172:519-524.
194. Aldovini A, Young RA: Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 1991;351:479-482.
195. Connell ND, Medina-Acosta E, McMaster WR, Bloom BR, Russell DG: Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63. Proc Natl Acad Sci USA 1993;90:11473-11477.
196. Li H, Ulstrup JC, Jonassen TO, Melby K, Nagai S, Harboe M: Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG. Infect Immun 1993;61:1730-1734.
197. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK: Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996;178:1274-1282.
198. Murray PJ, Aldovini A, Young RA: Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines. Proc Natl Acad Sci USA 1996;93:934-939.
199. Khan CM, Villarreal-Ramos B, Pierce RJ, Demarco-de-Hormaeche R, McNeill H, Ali T, Chatfield S, Capron A, Dougan G, Hormaeche CE: Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide 115-131 of the P28 glutathione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live aro-attenuated vaccine strain of Salmonella. J Immunol 1994;153:5634-5642.
200. Khan CM, Villarreal-Ramos B, Pierce RJ, Riveau G, Demarco-de-Hormaeche R, McNeill H, Ali T, Fairweather N, Chatfield S, Capron A, Dougan G, Hormaeche CE: Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc Natl Acad Sci USA 1994;91:11261-11265.
201. Lyons J, Sinos C, Destree A, Caiazzo T, Havican K, McKenzie S, Panicali D, Mahr A: Expression of Mycobacterium tuberculosis and Mycobacterium leprae proteins by vaccinia virus. Infect Immun 1990;58:4089-4098.
202. Baumgart KW, McKenzie KR, Radford AJ, Ramshaw I, Britton WJ: Immunogenicity and protection studies with recombinant mycobacteria and vaccinia vectors coexpressing the 18-kilodalton protein of Mycobacterium leprae. Infect Immun 1996;64:2274-2281.
203. Curtiss R III: Attenuated Salmonella strains as live vectors for the expression of foreign antigens: in Woodrow GC, Levine MM (eds): New Generation Vaccines. New York, Dekker, 1990, pp 161-188.
204. Norman E, Dellagostin OA, McFadden J, Dale JW: Gene replacement by homologous recombination in Mycobacterium bovis. Mol Microbiol 1995;16:755-760.
205. Balasubramanian V, Pavelka MS, Bardarov SS, Martin J, Weisbrod TR, McAdam RA, Bloom BR, Jacobs WR: Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates. J Bacteriol 1996;178:273-279.
206. Reyrat JM, Berthet FX, Gicquel B: The urease locus of Mycobacterium tuberculosis and its utilization for the demonstration of allelic exchange in Mycobacterium bovis bacillus Calmette-Guérin. Proc Natl Acad Sci USA 1995;92:8768-8772.
207. McAdam RA, Weisbrod TR, Martin J, Scuderi JD, Brown AM, Cirillo JD, Bloom BR, Jacobs WR: In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect Immun 1995;63:1004-1012.
208. Guleria I, Teitelbaum R, McAdam RA, Kalpana G, Jacobs WR, Bloom BR: Auxotrophic vaccines for tuberculosis. Nat Med 1996;2:334-337.
209. Montgomery DL, Shiver JW, Leander KR, Perry HC, Friedman A, Martinez D, Ulmer JB, Donnelly JJ, Liu MA: Heterologous and homologous protection against influenza A by DNA vaccination: Optimization of DNA vectors. DNA Cell Biol 1993;12:777-783.
210. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgomery DL, Liu MA: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993;259:1745-1749.
211. Donnelly JJ, Ulmer JB, Liu MA: Immunization with DNA. J Immunol Methods 1994;176:145-152.
212. Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR, DeWitt CM, Orme IM, Baldwin S, D'Souza C, Drowart A, Lozes E, Vandenbussche P, Van-Vooren JP, Liu MA, Ulmer JB: Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 1996;2:893-898.
213. Barry MA, Lai WC, Johnston SA: Protection against mycoplasma infection using expression-library immunization. Nature 1995;377:632-635.
214. Collins FM: Protection against mycobacterial disease by means of live vaccines tested in experimental animals; in Kubica GP, Wayne LG (eds.): The Mycobacterial Sourcebook. New York, Dekker, 1984, pp 787-840.
215. Smith DW, Wiegeshaus EH: What animal models can teach us about the pathogenesis of tuberculosis in humans. Rev Infect Dis 1989;11(suppl 2):385-393.
216. Walsh GP, Tan EV, de la Cruz EC, Abalos RM, Villahermosa LG, Young LJ, Cellona RV, Nazareno JB, Horwitz MA: The Phillipine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat Med 1996;2:430-436.
217. Young DB, Garbe TR: Heat shock proteins and antigens of Mycobacterium tuberculosis. Infect Immun 1991;59:3086-3093.
218. Young D, Lathigra R, Hendrix R, Sweetser D, Young RA: Stress proteins are immune targets in leprosy and tuberculosis. Proc Natl Acad Sci USA 1988;85:4267-4270.
219. Peake PW, Britton WJ, Davenport MP, Roche PW, McKenzie KR: Analysis of B-cell epitopes in the variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein. Infect Immun 1993;61:135-141.
220. Shinnick TM, Vodkin MH, Williams JC: The Mycobacterium tuberculosis 65-kilodalton antigen is a heat shock protein which corresponds to common antigen and to the Escherichia coli GroEL protein. Infect Immun 1988;56:446-451.
221. Rinke de Wit TF, Bekelie S, Osland A, Miko TL, Hermans PW, van Soolingen D, Drijfhout JW, Schoningh R, Janson AA, Thole JE: Mycobacteria contain two groEL genes: The second Mycobacterium leprae groEL gene is arranged in an operon with groES. Mol Microbiol 1992;6: 1995-2007.
222. Clemens DL, Lee BY, Horwitz MA: Purification, characterization, and genetic analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host-pathogen interaction. J Bacteriol 1995;177:5644-5652.
223. Harth G, Clemens DL, Horwitz MA: Glutamine synthetase of Mycobacterium tuberculosis: Extracellular release and characterization of its enzymatic activity. Proc Natl Acad Sci USA 1994;91: 9342-9346.
224. Romain F, Augier J, Pescher P, Marchal G: Isolation of a proline-rich mycobacterial protein eliciting delayed-type hypersensitivity reactions only in guinea pigs immunized with living mycobacteria. Proc Natl Acad Sci USA 1993;90:5322-5326.
225. Romain F, Laqueyrerie A, Militzer P, Pescher P, Chavarot P, Lagranderie M, Auregan G, Gheorghiu M, Marchal G: Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria. Infect Immun 1993;61:742-750.
226. Dobos KM, Khoo KH, Swiderek KM, Brennan PJ, Belisle JT: Definition of the full extent of glycosylation of the 45-kilodalton glycoprotein of Mycobacterium tuberculosis. J Bacteriol 1996; 178:2498-2506.
227. Andersen AB, Andersen P, Ljungqvist L: Structure and function of a 40,000-molecular-weight protein antigen of Mycobacterium tuberculosis. Infect Immun 1992;60:2317-2323.
228. Andersen AB, Ljungqvist L, Olsen M: Evidence that protein antigen b of Mycobacterium tuberculosis is involved in phosphate metabolism. J Gen Microbiol 1990;136:477-480.
229. Young DB, Garbe TR: Lipoprotein antigens of Mycobacterium tuberculosis. Res Microbiol 1991; 142:55-65.
230. Wiker HG, Harboe M: The antigen 85 complex: A major secretion product of Mycobacterium tuberculosis. Microbiol Rev 1992;56:648-661.
231. Belisle JT, Sievert T, Takayana K, Besra GS: Identification of a mycolyltransferase from Mycobacterium tuberculosis and the coincident definition of the physiological function of antigen 85B. In program of the 30th Joint Conference on Tuberculosis and Leprosy. US-Japan Cooperative Medical Science Program. NIAID. Fort Collins, NIH, 1995, pp 212-216.
232. Abou-Zeid C, Garbe T, Lathigra R, Wiker HG, Harboe M, Rook GA, Young DB: Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins. Infect Immun 1991;59:2712-2718.
233. Menozzi FD, Rouse JH, Alavi M, Laude-Sharp M, Muller J, Bischoff R, Brennan P, Locht C: Identification of a heparin-binding hemagglutinin present in mycobacteria. J Exp Med 1996;184: 993-1001.
234. Wiker HG, Nagai S, Harboe M, Ljungqvist L: A family of cross-reacting proteins secreted by Mycobacterium tuberculosis. Scand J Immunol 1992;36:307-319.
235. Kusunosc E, Ichihara K, Noda Y, Kusunose M: Superoxide dismutase from Mycobacterium tuberculosis. J Biochem Tokyo 1976;80:1343-1352.
236. Garbe T, Harris D, Vordermeier M, Lathigra R, Ivanyi J, Young D: Expression of the Mycobacterium tuberculosis 19-kilodalton antigen in Mycobacterium smegmatis: Immunological analysis and evidence of glycosylation. Infect Immun 1993;61:260-267.
237. Verbon A, Hartskeerl RA, Schuitema A, Kolk AH, Young DB, Lathigra R: The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins. J Bacteriol 1992;174:1352-1359.
238. Chang Z, Primm TP, Jakana J, Lee IH, Serysheva I, Chiu W, Gilbert HF, Quiocho FA: Mycobacterium tuberculosis 16-kDa antigen (Hsp 16.3) functions as an oligomeric struċture in vitro to supress thermal aggregation. J Biol Chem 1996;271:7218-7223.
239. Mehra V, Bloom BR, Bajardi AC, Grisso CL, Sieling PA, Alland D, Convit J, Fan XD, Hunter SW, Brennan PJ, Rea TH, Modlin RL: A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med 1992;175:275-284.
240. Mande SC, Mehra V, Bloom BR, Hol WG: Structure of the heat shock protein chaperonin-10 of Mycobacterium leprae. Science 1996;271:203-207.